Webinar Date & Time: Tuesday, April 14, 2020 – 1:00pm EST

CMIC Group will be joining Nuventra Pharma Sciences‘ webinar on April 14th at 1:00pm EST for the second live panel discussion on drug development during the COVID-19 pandemic. The panel will have industry experts discuss the latest impacts on Phase 1 clinical trials and how labs are adjusting to the crisis.

Topics will include:

  • Regulatory impacts from a former FDA reviewer
  • The latest impact on ongoing and planned clinical trials from a Phase 1 site
  • How labs are adjusting to the crisis
  • FAQs from our clients and colleagues

Register on the Nuventra Pharma Sciences website and join us on April 14, 2020 for this informative drug development discussion: https://www.nuventra.com/resources/events/covid-19-pandemic-panel-discussion-part-2/